Inclusion of Metabolic Tumor Volume in Prognostic Models of Bone and Soft Tissue Sarcoma Increases the Prognostic Value

SIMPLE SUMMARY: Sarcoma is a rare cancer originating in soft tissue or bone. Prognostic models are used to modify therapy and improve survival. The present study aimed to evaluate if the combination of PET parameters and circulating biomarkers can improve the prognostic accuracy. When PET parameters...

Descripción completa

Detalles Bibliográficos
Autores principales: Pedersen, Mette Abildgaard, Baad-Hansen, Thomas, Gormsen, Lars C., Bærentzen, Steen, Sandfeld-Paulsen, Birgitte, Aggerholm-Pedersen, Ninna, Vendelbo, Mikkel Holm
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9913525/
https://www.ncbi.nlm.nih.gov/pubmed/36765774
http://dx.doi.org/10.3390/cancers15030816

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9913525/
https://www.ncbi.nlm.nih.gov/pubmed/36765774
http://dx.doi.org/10.3390/cancers15030816

Ejemplares similares